Clinical Study

Effect Of Duloextine 30/60 Mg Once Daily Versus Placebo In Adolescents With Juvenile Primary Fibromyalgia Syndrome

Posted Date: Jul 6, 2017

  • Investigator: Lesley Arnold
  • Co-Investigator: Lesley Arnold
  • Specialties:
  • Type of Study: Drug

This is a research study to look at how safe and effective an investigational medication is for teens who have symptoms of fibromyalgia.

Criteria:

Teens 13 To 17 Years Old Who Have Been Diagnosed With Fibromyalgia Or Who Have Had Muscle Aches Or Pains For At Least Three Months May Be Eligible To Participate.

Keywords:

Fibromyalgia, Pediatric Fibromyalgia, Null, Null, Null

For More Information:

Kerri Earles
513-558-7104
kerri.earles@uc.edu

  • Search Clinical Studies

  • Research in the News

    Targeted Treatment Could Prevent Spread of Pancreatic Cancer, Heart Damage

    Researchers at the UC College of Medicine have shown that a new targetedtreatment could benefit patients with certain pancreatic tumors.